Search

Search results

202 results found

Jessica Felix Joins the Rosen Lab

News: March 01, 2026

Jessica Felix is a new post-doc in the Rosen lab. Jessica did her graduate work in Sean Hartig’s lab at Baylor College of Medicine, where she did outstanding work to identify N-acetylaspartate as an adipocyte-derived metabolite that regulates body temperature ( https://pubmed.ncbi.nlm.nih.gov...

Effect of Low-Carbohydrate and Low-Fat Diets on Metabolomic Indices and Coronary Heart Disease in U.S. Individuals.

Publication: Journal Article

Wu, Zhiyuan, Binkai Liu, Xiaowen Wang, Hala Alessa, Oana A Zeleznik, Heather Eliassen, Clary Clish, et al. 2026. “Effect of Low-Carbohydrate and Low-Fat Diets on Metabolomic Indices and Coronary Heart Disease in U.S. Individuals.”. Journal of the American College of Cardiology.

Enrollment, Retention, and Adherence in a Fully Remote Pilot Randomized Controlled Trial of Alcohol Abstinence.

Publication: Journal Article

Noubiap, Jean Jacques, Kenneth J Mukamal, Alexis L Beatty, Mark J Pletcher, Jeffrey E Olgin, and Gregory M Marcus. 2026. “Enrollment, Retention, and Adherence in a Fully Remote Pilot Randomized Controlled Trial of Alcohol Abstinence.”. Circulation. Population Health and Outcomes 19 (1): e012541.

Human plasma proteomic profile of clonal hematopoiesis.

Publication: Journal Article

Yu, Zhi, Amélie Vromman, Ngoc Quynh H Nguyen, Art Schuermans, Linke Li, Thiago Rentz, Tetsushi Nakao, et al. 2025. “Human Plasma Proteomic Profile of Clonal Hematopoiesis.”. Nature Communications 16 (1): 11688.

Accelerating Discovery: How AI Is Transforming the Lab

Events: Monday, Mar 30, 2026, 12:00pm -Monday, Mar 30, 2026, 01:00pm

Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials.

Publication: Journal Article

Pinkerton, JoAnn, V, James A Simon, Hadine Joffe, Pauline M Maki, Rossella E Nappi, Nick Panay, Claudio N Soares, et al. 2024. “Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials.”. JAMA 332 (16): 1343-54.

Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.

Publication: Journal Article

Refardt, Julie, Cornelia Imber, Rianne Nobbenhuis, Clara O Sailer, Aaron Haslbauer, Sophie Monnerat, Cemile Bathelt, et al. 2023. “Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.”. Journal of the American Society of Nephrology : JASN 34 (2): 322-32.

Effects of GLP-1 receptor agonists on copeptin in euvolemic participants.

Publication: Journal Article

Leibnitz, Svenja, Bettina Winzeler, Julie Refardt, Deborah R Vogt, Clara O Sailer, and Mirjam Christ-Crain. 2026. “Effects of GLP-1 Receptor Agonists on Copeptin in Euvolemic Participants.”. European Journal of Endocrinology 194 (2): 91-101.

Changes in fibroblast growth factor 21 levels associated with alcohol consumption and smoking cessation.

Publication: Journal Article

Sailer, Clara O, Cyril F Vogel, Sophie Monnerat, Leila Probst, Mirjam Christ-Crain, Bettina Winzeler, and Julie Refardt. 2026. “Changes in Fibroblast Growth Factor 21 Levels Associated With Alcohol Consumption and Smoking Cessation.”. Endocrine Connections 15 (1).

Neural underpinnings of food choice and consumption in obesity.

Publication: Journal Article

Christensen, Erynn L, Ian H Harding, Katharina Voigt, Trevor T-J Chong, and Antonio Verdejo-Garcia. 2022. “Neural Underpinnings of Food Choice and Consumption in Obesity.”. International Journal of Obesity (2005) 46 (1): 194-201.